Effects of brief pain education on hospitalized cancer patients with moderate to severe pain

被引:58
作者
Lai, YH
Guo, SL
Keefe, FJ
Tsai, SL
Chien, CC
Sung, YC
Chen, ML
机构
[1] Taipei Med Univ, Coll Nursing, Taipei 110, Taiwan
[2] Cathay Gen HOsp, Dept Nursing, Taipei 106, Taiwan
[3] Duke Univ, Med Ctr, Pain Prevent & Treatment Res Program, Durham, NC 27710 USA
[4] Taipei Vet Gen Hosp, Dept Nursing, Taipei 112, Taiwan
[5] Cathay Gen Hosp, Dept Anesthesiol, Taipei 106, Taiwan
关键词
cancer pain; pain education; pain beliefs; pain interference; catastrophizing;
D O I
10.1007/s00520-004-0626-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this randomized controlled study was to assess the effects of a structured pain education program on the pain experience of hospitalized cancer patients. Eligible cancer pain patients were randomly assigned to either an experimental group (receiving pain education 10-15 min per day for 5 days, n=15) or a standard care control group (n=15). The effects of the intervention on six pain-related variables were evaluated using three instruments. Pain intensity, pain interference with daily life, negative beliefs about opioids, beliefs about endurance of pain, pain catastrophizing (an individual's tendency to focus on and exaggerate the threat value of painful stimuli and negatively evaluate his or her own ability to deal with pain), and sense of control over pain were evaluated by the Brief Pain Inventory-Short Form Taiwanese version (BPI-T), Pain and Opioid Analgesic Beliefs Scale-Cancer (POABS-CA), and the Catastrophizing subscale and the sense of control over pain measure from the Coping Strategies Questionnaire (CSQ). The results indicated that, after completing treatment, patients who had received structured pain education had significantly less pain intensity on average, negative pain beliefs regarding opioids, pain endurance beliefs, and pain catastrophizing than patients in the control group. In addition, patients in the pain education group showed a significant increase in their sense of control over pain. These preliminary results strongly suggest that structured pain education can effectively improve the pain experience of hospitalized cancer patients and should be further implemented clinically.
引用
收藏
页码:645 / 652
页数:8
相关论文
共 50 条
[31]   Effects of pain education delivered through telerehabilitation on pain and disability in patients with chronic musculoskeletal pain: A systematic review protocol [J].
Velho, Gabriel ;
de Araujo, Francisco Xavier ;
da Silva, Carlos Vicente ;
Machado, Jodelle Chagas ;
da Silva, Fabiana Cristina ;
Hoegh, Morten Sebastian ;
Silva, Marcelo Faria .
INTERNATIONAL JOURNAL OF OSTEOPATHIC MEDICINE, 2025, 55
[32]   Grading the intensity of nondental orofacial pain: identification of cutoff points for mild, moderate, and severe pain [J].
Brailo, Vlaho ;
Zakrzewska, Joanna M. .
JOURNAL OF PAIN RESEARCH, 2015, 8 :95-104
[33]   Tramadol as an analgesic for mild to moderate cancer pain [J].
Wojciech Leppert .
Pharmacological Reports, 2009, 61 :978-992
[34]   Tramadol as an analgesic for mild to moderate cancer pain [J].
Leppert, Wojciech .
PHARMACOLOGICAL REPORTS, 2009, 61 (06) :978-992
[35]   Bedside charting of pain levels in hospitalized patients with cancer: A randomized controlled trial [J].
Kravitz, RL ;
Delafield, JP ;
Hays, RD ;
Drazin, R ;
Conolly, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1996, 11 (02) :81-87
[36]   Breakthrough Pain in Patients With Abdominal Cancer Pain [J].
Mercadante, Sebastiano ;
Adile, Claudio ;
Giarratano, Antonino ;
Casuccio, Alessandra .
CLINICAL JOURNAL OF PAIN, 2014, 30 (06) :510-514
[37]   Severity, interference, qualities, and correlates of severe pain: Descriptive cross-sectional study on pain experience of cancer patients in Sri Lanka [J].
Edirisinghe, N. P. ;
Makuloluwa, P. T. R. ;
Amarasekara, A. A. T. D. ;
Goonewardena, C. S. E. .
CHRONIC ILLNESS, 2024, 20 (03) :515-526
[38]   Dihydrocodeine as an Opioid Analgesic for the Treatment of Moderate to Severe Chronic Pain [J].
Leppert, Wojciech .
CURRENT DRUG METABOLISM, 2010, 11 (06) :494-506
[39]   Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain [J].
Chwistek, Marcin ;
Sherry, Dylan ;
Kinczewski, Leigh ;
Silveira, Maria J. ;
Davis, Mellar .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2023, 66 (05) :e638-e643
[40]   Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain [J].
Hongming Pan ;
Zaiyun Zhang ;
Yiping Zhang ;
Nong Xu ;
Liqin Lu ;
Chunfeng Dou ;
Yong Guo ;
Shixiu Wu ;
Jianhua Yue ;
Dongping Wu ;
Yuechu Dai .
Clinical Drug Investigation, 2007, 27 :259-267